Skip to main content
Log in

Cellular pharmacokinetics of daunorubicin: Uptake by leukaemic cells in vivo and fate

  • Short Communications
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

In 6 patients with acute myeloblastic leukaemia, daunorubicin was assayed in leukaemic cells from peripheral blood or bone marrow. The cells were separated from red blood cells and granulocytes by centrifugation on a Ficoll-Isopac gradient. The assay was performed by high performance liquid chromatography. Daunorubicin concentrations in peripheral leukaemic cells, 2 hours after the end of the infusion, were much higher than in plasma, the cell/plasma concentration ratio reaching about 350 and rising to almost 700 at 24 h. At that time, drug concentrations were even higher in the bone marrow leukaemic cells. The value of the assay of daunorubicin in cells as method for monitoring therapy is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Chervinsky DS, Wang JJ (1976) Uptake of adriamycin and daunomycin in L 1210 and human leukemia cells: A comparative study. J Med 7: 63–79

    Google Scholar 

  • Noël G, Peterson C, Trouet A, Tulkens P (1978) Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts. Eur J Cancer 14: 363–368

    Google Scholar 

  • Paul C, Baurain R, Gahrton G, Peterson C (1980) Determination of daunorubicin and its main metabolites in plasma, urine and leukemic cells in patients with acute myeloblastic leukemia. Cancer Lett 9: 263–269

    Google Scholar 

  • Peterson C, Baurain R, Trouet A (1980) The mechanism for cellular uptake, storage and release of daunorubicin. Biochem Pharmacol 29: 1687–1692

    Google Scholar 

  • Ritter J, Durand F, Fière D, Brazier JL, Faucon G (1984) Daunorubicine et éléments figurés sanguins. Fixation et métabolisme. Thérapie 39: 131–137

    Google Scholar 

  • Schneider YJ, Baurain R, Zenebergh A, Trouet A (1979) DNA-binding parameters of daunorubicin and doxorubicin in the conditions used for studying the interaction of anthracycline-DNA complexes with cells in vitro. Cancer Chemother Pharmacol 2: 7–10

    Google Scholar 

  • Strauss JP, Kitchens RL, Patrizi VW, Frenkel EP (1980) Extraction and quantification of daunorubicin and doxorubicin in tissues. J Chromatogr 221: 139–144

    Google Scholar 

  • Yamamoto K, Acton EM, Henry DW (1972) Antitumor activity of some derivatives of daunorubicin at the amino and methyl ketone functions. J Med Chem 15: 872–875

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trillet, V., Lakhal, M., Lang, J. et al. Cellular pharmacokinetics of daunorubicin: Uptake by leukaemic cells in vivo and fate. Eur J Clin Pharmacol 29, 127–129 (1985). https://doi.org/10.1007/BF00547382

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00547382

Key words

Navigation